USSTOCK.TODAY
Market Closed
Log in Sign up

TG Therapeutics Beats Wall Street Estimates for Q3 Earnings and Revenue

Associated Press · ·by G4L

TGTX
TGTX TG Therapeutics Inc
$64.26 +1.39%
View chart & analysis →
  1. 1TG Therapeutics reported Q3 earnings of $55.5 million.
  2. 2TG Therapeutics reported Q3 earnings per share of 35 cents.
  3. 3TG Therapeutics revenue of $259.9 million exceeded Wall Street estimates.

So what's the key point?

TG Therapeutics earned more money in the third quarter than experts expected. This means revenue reached $259.9 million, which was higher than anticipated.

Source Associated Press · View original ↗

Related 3-line summaries

TG Therapeutics Reports Q3 Revenue Growth and Raises Annual Guidance to $1 billion The Motley Fool +1 · 18h agoTG Therapeutics Raises 2026 Revenue Outlook on Strong Briumvi Sales InvestorsHub +5 · Aug 3Wall Street strategists predict S&P 500 correction phase nearing end Investing.com · yesterday
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news